Combating Counterfeit Pharmaceuticals Act of 2025

This bill would change the Fentanyl Sanctions Act so that it covers trafficking in counterfeit drugs and "copy-cat" ingredients, not only opioids. A copy-cat ingredient is one that claims to be an ingredient in an approved prescription drug but is made by a different process or is of lower purity or quality. The bill would let the Director of National Intelligence hand certain identification and briefing duties to a designee. It would limit the sanctions waiver for prescription medications to drugs on the federal drug shortage list. It would also replace the word "opioid" with "illicit drug" throughout the law.

Full text and official record on Congress.gov

Sponsors

• Tom Cotton Republican sponsor
• 1 cosponsors